Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2014


Allergies 2014

09 Jul 2014 - 10 Jul 2014 - London, UK



Bookmark and Share


Analyse industry developments and the future of allergy therapeutics

The launch event for Allergies is here and will be taking place on 9th July and 10th July 2014 in Central London. The market for Allergies is expected to reach $14.7 billion by 2015. As companies look to develop different compounds and antibodies to treat allergies, this event will mark the path forward in terms of allergies within personalised medicines and beyond.

We have worked in partnership with an expert advisory board which includes KOLs from Imperial College London, Swecure AB and GSK, to put together an exciting conference agenda.

The programme will examine key areas such as novel approaches in the treatment of allergy, therapeutic advances, allergic pathophysiology, current update on food allergies, the future of allergen-specific immunotherapy and challenges, allergy prevention, diagnosis and drug development plus much more. 

Reasons to Attend:

  • Key case study presentation from GSK on new therapeutic tools for allergies
  • Clinicians' perspective – advances in allergy diagnostics featuring Royal Free Hospital and Imperial College London
  • Allergy specialists – Dr Scadding and Dr Church present on new research and findings
  • Exclusive case study on the success of peanut allergy trials
  • Evaluate new breakthroughs in allergy treatment and gain understanding into guidance on development novel therapeutics
  • Analyse current and novel approaches of allergen-specific immunotherapy 

Key Speakers Include:

  • Daphne Tsitoura, Senior Medical Director, Clinical Drug Development / Discovery Medicine, GSK
  • Professor Alf Lindberg, Chief Scientific Director, Swecure AB
  • Dr Rainer Henning, CEO, Biomay AG
  • Dr Donna Finch, Principal Scientist, MedImmune
  • Dr Glenis Scadding, Honorary Consultant Allergist & Rhinologist, Royal National Throat, Nose and Ear Hospital
  • Calman Prussin, Principal Investigator, National Institute of Allergy and Infectious Diseases(NIAID)
  • Professor Rudolf Valenta, Professor for Allergology, Medical University of Vienna

To register online or to download a brochure visit http://www.smi-online.co.uk/goto/allergies7.asp

Alternatively contact John Collins on +44 (0)20 7827 6734 or email jcollins@smi-online.co.uk




Further information
Scientific News
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Switch Lets Salmonella Fight, Evade Immune System
Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Neural Networks Adapt to the Presence of a Toxic HIV Protein
HIV-associated neurocognitive disorders (HAND) afflict approximately half of HIV infected patients.
HIV Protein Manipulates Hundreds of Human Genes
Findings search for new or improved treatments for patients with AIDS.
Breaking the Brain’s Garbage Disposal
The children’s ataxia gene problem turned out to be not such a big deal genetically — it was such a slight mutation that it barely changed the way the cells made the protein.
Flesh-Eating Bacteria Work Together
Scientists recently discovered different strains of deadly flesh-eating bacteria working together to spread infection and they now have a better understanding of the role of the toxins they produce. The discovery could change how the illness and other diseases are treated.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!